Telesis Bio, Inc. (DNAY) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Todd Nelson - CEO Brent Hunter - VP, Finance Conference Call Participants Brandon Couillard - Jefferies Operator Welcome to the Q3 2022 Telesis Bio Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the call over to your speaker today, CEO, Todd Nelson. Please go ahead. Todd Nelson Thank you. Good afternoon, and thanks ...

Codex DNA, Inc. (DNAY) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Todd Nelson - Chief Executive Officer Brent Hunter - VP of Finance Conference Call Participants Brandon Couillard - Jefferies Operator Good day, and thank you for standing by. Welcome to the Q2 2022 Codex DNA, Incorporated Earnings Conference Call. [Operator instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Todd Ne ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission file number 001-40497 CODEX DNA, INC. (Exact name of registrant as specified in its charter) (State o ...

BUILDING BIOLOGY Codex DNA presentation | May 2022 SAFE HARBOR STATEMENT 2 The information contained in this presentation has been made available to you with the consent of Codex DNA ("Codex DNA," the "Company," "we" or "our") for informational purposes only. This presentation is strictly confidential and may not be reproduced or redistributed in whole or in part nor may its contents be disclosed to any other person without our prior written permission. By viewing this presentation, you agree to keep any in ...

Codex DNA, Inc. (DNAY) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Richard Lepke - Director, Investor Relations Todd Nelson - Chief Executive Officer Jennifer McNealey - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Paul Knight - KeyBanc Steven Mah - Cowen Operator Good afternoon, ladies and gentlemen and welcome to the Quarter One 2022 Codex DNA Incorporated Earnings Conference Call. [Operator Instructions] I would now like to turn the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission file number 001-40497 CODEX DNA, INC. (Exact name of registrant as specified in its charter) Delawar ...

Q4'2021 EARNINGS PRESENTATION Codex DNA presentation | March 2022 SAFE HARBOR STATEMENT 2 The information contained in this presentation has been made available to you with the consent of Codex DNA ("Codex DNA," the "Company," "we" or "our") for informational purposes only. This presentation is strictly confidential and may not be reproduced or redistributed in whole or in part nor may its contents be disclosed to any other person without our prior written permission. By viewing this presentation, you agree ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40497 Codex DNA, INC. (Exact name of registrant as specified in its charter) Delaware 45-1216839 (State or other ju ...

Codex DNA, Inc. (DNAY) Q4 2021 Earnings Conference Call March 22, 2022 4:30 PM ET Company Participants Richard Lepke - Director, Investor Relations Todd Nelson - Chief Executive Officer Dan Gibson - Chief Technology Officer Jennifer McNealey - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Paul Knight - KeyBanc Operator Thank you for standing by and welcome to the Fourth Quarter 2021 Codex DNA Earnings Conference Call. [Operator Instructions] I would now like to hand the ...

BUILDING BIOLOGY Codex DNA presentation | March 2022 SAFE HARBOR STATEMENT 2 The information contained in this presentation has been made available to you with the consent of Codex DNA ("Codex DNA," the "Company," "we" or "our") for informational purposes only. This presentation is strictly confidential and may not be reproduced or redistributed in whole or in part nor may its contents be disclosed to any other person without our prior written permission. By viewing this presentation, you agree to keep any ...